FTC Investigates Valeant's Dermatology Buys
Valeant Pharmaceuticals International Inc. said Tuesday that the Federal Trade Commission had made two separate requests for additional information related to its $770 million plans to purchase a pair of companies...To view the full article, register now.
Already a subscriber? Click here to view full article